BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hiebert LM, Liu JM. Heparin protects cultured arterial endothelial cells from damage by toxic oxygen metabolites. Atherosclerosis. 1990;83:47-51. [PMID: 2390135 DOI: 10.1016/0021-9150(90)90129-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang X, Li X. The Role of Histones and Heparin in Sepsis: A Review. J Intensive Care Med 2021;:885066621992320. [PMID: 33626964 DOI: 10.1177/0885066621992320] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Tsai T, Leong I, Cheng K, Shiao L, Su T, Wong K, Chan P, Leung Y. Lysophosphatidylcholine-induced cytotoxicity and protection by heparin in mouse brain bEND.3 endothelial cells. Fundam Clin Pharmacol 2019;33:52-62. [DOI: 10.1111/fcp.12399] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
3 Li X, Ma X. The role of heparin in sepsis: much more than just an anticoagulant. Br J Haematol 2017;179:389-98. [PMID: 28832958 DOI: 10.1111/bjh.14885] [Cited by in Crossref: 40] [Cited by in F6Publishing: 54] [Article Influence: 8.0] [Reference Citation Analysis]
4 Hiebert LM, Liu J. Dextran Sulphates Protect Porcine Arterial Endothelial Cells from Free Radical Injury. Hum Exp Toxicol 1994;13:233-9. [DOI: 10.1177/096032719401300402] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
5 Hiebert LM, Han J, Mandal AK. Glycosaminoglycans, hyperglycemia, and disease. Antioxid Redox Signal 2014;21:1032-43. [PMID: 24224492 DOI: 10.1089/ars.2013.5695] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
6 Qian Y, Xie H, Tian R, Yu K, Wang R. Efficacy of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support. COPD 2014;11:171-6. [PMID: 24087989 DOI: 10.3109/15412555.2013.831062] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
7 McNair ED, Wells CR, Qureshi AM, Pearce C, Caspar-Bell G, Prasad K. Inverse Association between Cardiac Troponin-I and Soluble Receptor for Advanced Glycation End Products in Patients with Non-ST-Segment Elevation Myocardial Infarction. Int J Angiol 2011;20:49-54. [PMID: 22532771 DOI: 10.1055/s-0031-1272552] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
8 Kmandal A, Neki NS. Diabetes: a pragmatic therapy with a goal to prevent end stage kidney disease and dialysis. OJIM 2011;01:80-92. [DOI: 10.4236/ojim.2011.13017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Freitas FA, Piccinato CE, Cherri J, Marchesan WG. Effects of pentoxyfilline and heparin on reperfusion injury island skin flaps in rats exposed to tobacco. J Surg Res 2010;164:139-45. [PMID: 20739032 DOI: 10.1016/j.jss.2010.05.028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
10 Baker PN, Davidge ST, Pitt BR, Davies P, Roberts JM. Plasma from Preeclamptic Women Causes a Rapid, Calcium-Sensitive Release of Nitric Oxide from Vascular Smooth Muscle Cells. Hypertension in Pregnancy 2009;16:47-63. [DOI: 10.3109/10641959709069089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
11 Prasad K. Vitamin E Does Not Regress Hypercholesterolemic Atherosclerosis. J Cardiovasc Pharmacol Ther 2009;14:231-41. [DOI: 10.1177/1074248409337003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
12 Gottmann U, Mueller-Falcke A, Schnuelle P, Birck R, Nickeleit V, van der Woude FJ, Yard BA, Braun C. Influence of hypersulfated and low molecular weight heparins on ischemia/reperfusion: injury and allograft rejection in rat kidneys. Transpl Int 2007;20:542-9. [PMID: 17355246 DOI: 10.1111/j.1432-2277.2007.00471.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
13 Han J, Mandal AK, Hiebert LM. Endothelial cell injury by high glucose and heparanase is prevented by insulin, heparin and basic fibroblast growth factor. Cardiovasc Diabetol 2005;4:12. [PMID: 16086844 DOI: 10.1186/1475-2840-4-12] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
14 Levidiotis V, Power DA. New insights into the molecular biology of the glomerular filtration barrier and associated disease. Review Article. Nephrology 2005;10:157-66. [DOI: 10.1111/j.1440-1797.2005.00385.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
15 Keshavarzian A, Farhadi A, Mutlu EA. New developments in the treatment of inflammatory bowel disease. Expert Opinion on Investigational Drugs 2005;11:365-85. [DOI: 10.1517/13543784.11.3.365] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
16 Dobosz M, Mionskowska L, Hać S, Dobrowolski S, Dymecki D, Wajda Z. Heparin improves organ microcirculatory disturbances in caerulein-induced acute pancreatitis in rats. World J Gastroenterol 2004; 10(17): 2553-2556 [PMID: 15300904 DOI: 10.3748/wjg.v10.i17.2553] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
17 Rabenstein T, Roggenbuck S, Framke B, Martus P, Fischer B, Nusko G, Muehldorfer S, Hochberger J, Ell C, Hahn EG. Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP? Gastrointest Endosc. 2002;55:476-483. [PMID: 11923757 DOI: 10.1067/mge.2002.122616] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 2.3] [Reference Citation Analysis]
18 Nakamura T, Vollmar B, Winning J, Ueda M, Menger MD, Schäfers HJ. Heparin and the nonanticoagulant N-acetyl heparin attenuate capillary no-reflow after normothermic ischemia of the lung. Ann Thorac Surg 2001;72:1183-8; discussion 1188-9. [PMID: 11603434 DOI: 10.1016/s0003-4975(01)02959-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
19 Saliba MJ Jr. Heparin in the treatment of burns: a review. Burns 2001;27:349-58. [PMID: 11348743 DOI: 10.1016/s0305-4179(00)00130-3] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 3.5] [Reference Citation Analysis]
20 Braun C, Schultz M, Fang L, Schaub M, Back WE, Herr D, Laux V, Rohmeiss P, Schnuelle P, van der Woude FJ. TREATMENT OF CHRONIC RENAL ALLOGRAFT REJECTION IN RATS WITH A LOW-MOLECULAR-WEIGHT HEPARIN (REVIPARIN): . Transplantation 2001;72:209-15. [DOI: 10.1097/00007890-200107270-00007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
21 Braun C, Schultz M, Schaub M, Fang L, Back WE, Herr D, Laux V, Schnuelle P, Rohmeiss P, van der Woude FJ. Effect of treatment with low-molecular-weight heparin on chronic renal allograft rejection in rats. Transplant Proc 2001;33:363-5. [PMID: 11266863 DOI: 10.1016/s0041-1345(00)02049-2] [Reference Citation Analysis]
22 San T, Moini H, Emerk K, Bilsel S. Protective effect of defibrotide on perfusion induced endothelial damage. Thromb Res 2000;99:335-41. [PMID: 10963784 DOI: 10.1016/s0049-3848(00)00256-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
23 Raats CJI, Van Den Born J, Berden J. Glomerular heparan sulfate alterations: Mechanisms and relevance for proteinuria. Kidney International 2000;57:385-400. [DOI: 10.1046/j.1523-1755.2000.00858.x] [Cited by in Crossref: 129] [Cited by in F6Publishing: 118] [Article Influence: 5.9] [Reference Citation Analysis]
24 Salas A, Sans M, Soriano A, Reverter JC, Anderson DC, Piqué JM, Panés J. Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism. Gut 2000;47:88-96. [PMID: 10861269 DOI: 10.1136/gut.47.1.88] [Cited by in Crossref: 98] [Cited by in F6Publishing: 92] [Article Influence: 4.5] [Reference Citation Analysis]
25 Ishikawa Y, Kitamura M. Inhibition of glomerular cell apoptosis by heparin. Kidney Int 1999;56:954-63. [PMID: 10469363 DOI: 10.1046/j.1523-1755.1999.00639.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 1.5] [Reference Citation Analysis]
26 Arai H, Kashiwagi S, Nagasaka Y, Uchida K, Hoshii Y, Nakamura K. Oxidative Modification of Apolipoprotein E in Human Very-Low-Density Lipoprotein and Its Inhibition by Glycosaminoglycans. Archives of Biochemistry and Biophysics 1999;367:1-8. [DOI: 10.1006/abbi.1999.1222] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 1.7] [Reference Citation Analysis]
27 Kitamura M, Fine LG. The concept of glomerular self-defense. Kidney International 1999;55:1639-71. [DOI: 10.1046/j.1523-1755.1999.00425.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 1.9] [Reference Citation Analysis]
28 Houston M, Estevez A, Chumley P, Aslan M, Marklund S, Parks DA, Freeman BA. Binding of Xanthine Oxidase to Vascular Endothelium. Journal of Biological Chemistry 1999;274:4985-94. [DOI: 10.1074/jbc.274.8.4985] [Cited by in Crossref: 175] [Cited by in F6Publishing: 164] [Article Influence: 7.6] [Reference Citation Analysis]
29 Fowler JD, Li X, Cooley BC. Brief ex vivo perfusion with heparinized and/or citrated whole blood enhances tolerance of free muscle flaps to prolonged ischemia. Microsurgery 1999;19:135-40. [DOI: 10.1002/(sici)1098-2752(1999)19:3<135::aid-micr3>3.0.co;2-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
30 Parks DA, Skinner KA, Skinner HB, Tan S. Multiple organ dysfunction syndrome: Role of xanthine oxidase and nitric oxide. Pathophysiology 1998;5:49-66. [DOI: 10.1016/s0928-4680(98)00008-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
31 Raats CJ, Bakker MA, van den Born J, Berden JH. Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome. J Biol Chem 1997;272:26734-41. [PMID: 9334259 DOI: 10.1074/jbc.272.42.26734] [Cited by in Crossref: 86] [Cited by in F6Publishing: 82] [Article Influence: 3.4] [Reference Citation Analysis]
32 Upchurch GR, Welch GN, Freedman JE, Fabian AJ, Pigazzi A, Scribner AM, Alpert CS, Keaney JF, Loscalzo J. High-dose heparin decreases nitric oxide production by cultured bovine endothelial cells. Circulation. 1997;95:2115-2121. [PMID: 9133522 DOI: 10.1161/01.cir.95.8.2115] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
33 Cardigan RA, Mackie I, Machin S. Hemostatic-endothelial interactions: A potential anticoagulant role of the endothelium in the pulmonary circulation during cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia 1997;11:329-36. [DOI: 10.1016/s1053-0770(97)90103-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
34 Radi R, Rubbo H, Bush K, Freeman BA. Xanthine Oxidase Binding to Glycosaminoglycans: Kinetics and Superoxide Dismutase Interactions of Immobilized Xanthine Oxidase–Heparin Complexes. Archives of Biochemistry and Biophysics 1997;339:125-35. [DOI: 10.1006/abbi.1996.9844] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 3.1] [Reference Citation Analysis]
35 Goode HF, Richardson N, Myers DS, Howdle PD, Walker BE, Webster NR. The effect of anticoagulant choice on apparent total antioxidant capacity using three different methods. Ann Clin Biochem 1995;32 ( Pt 4):413-6. [PMID: 7486802 DOI: 10.1177/000456329503200410] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
36 Stavenow L, Lindblad B, Xu CB. Unfractionated heparin and low molecular weight heparin do not inhibit the growth of proliferating human arterial smooth muscle cells in culture. Eur J Vasc Endovasc Surg 1995;10:215-9. [PMID: 7655975 DOI: 10.1016/s1078-5884(05)80115-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
37 Li X, Cooley BC, Fowler JD, Gould JS. Intravascular heparin protects muscle flaps from ischemia/reperfusion injury. Microsurgery 1995;16:90-3. [DOI: 10.1002/micr.1920160209] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
38 Friedrichs GS, Kilgore KS, Manley PJ, Gralinski MR, Lucchesi BR. Effects of heparin and N-acetyl heparin on ischemia/reperfusion-induced alterations in myocardial function in the rabbit isolated heart. Circ Res 1994;75:701-10. [DOI: 10.1161/01.res.75.4.701] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 2.1] [Reference Citation Analysis]
39 Grant D, Long WF, Mackintosh G, Williamson FB. Heparins as essential antioxidants. Agents and Actions 1994;41:C214-5. [DOI: 10.1007/bf01987642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
40 Tan S, Yokoyama Y, Dickens E, Cash TG, Freeman BA, Parks DA. Xanthine oxidase activity in the circulation of rats following hemorrhagic shock. Free Radic Biol Med 1993;15:407-14. [PMID: 8225022 DOI: 10.1016/0891-5849(93)90040-2] [Cited by in Crossref: 99] [Cited by in F6Publishing: 83] [Article Influence: 3.4] [Reference Citation Analysis]
41 Sobotka PA, Brottman MD, Weitz Z, Birnbaum AJ, Skosey JL, Zarling EJ. Elevated breath pentane in heart failure reduced by free radical scavenger. Free Radical Biology and Medicine 1993;14:643-7. [DOI: 10.1016/0891-5849(93)90145-k] [Cited by in Crossref: 77] [Cited by in F6Publishing: 61] [Article Influence: 2.7] [Reference Citation Analysis]
42 Nilsson UA, Haraldsson G, Bratell S, Sørensen V, Akerlund S, Pettersson S, Scherstén T, Jonsson O. ESR-measurement of oxygen radicals in vivo after renal ischaemia in the rabbit. Effects of pre-treatment with superoxide dismutase and heparin. Acta Physiol Scand 1993;147:263-70. [PMID: 8386425 DOI: 10.1111/j.1748-1716.1993.tb09498.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 0.9] [Reference Citation Analysis]
43 Sternbergh WC, Makhoul RG, Adelman B. Heparin prevents postischemic endothelial cell dysfunction by a mechanism independent of its anticoagulant activity. J Vasc Surg. 1993;17:318-327. [PMID: 8433427 DOI: 10.1016/0741-5214(93)90417-k] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
44 Blankenhorn DH, Selzer RH, Mack WJ, Crawford DW, Pogoda J, Lee PL, Shircore AM, Azen SP. Evaluation of colestipol/niacin therapy with computer-derived coronary end point measures. A comparison of different measures of treatment effect. Circulation 1992;86:1701-9. [DOI: 10.1161/01.cir.86.6.1701] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
45 Ross MA, Long WF, Williamson FB. Inhibition by heparin of Fe(II)-catalysed free-radical peroxidation of linolenic acid. Biochem J 1992;286 ( Pt 3):717-20. [PMID: 1417730 DOI: 10.1042/bj2860717] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 0.9] [Reference Citation Analysis]
46 Wardle EN. Altering the course of proliferative nephritides: the challenge of the 1990s. J Int Med Res 1992;20:361-70. [PMID: 1280605 DOI: 10.1177/030006059202000501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
47 Lapenna D, Mezzetti A, de Gioia S, Ciofani G, Marzio L, Di Ilio C, Cuccurullo F. Heparin: does it act as an antioxidant in vivo? Biochem Pharmacol 1992;44:188-91. [PMID: 1321628 DOI: 10.1016/0006-2952(92)90057-p] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 0.7] [Reference Citation Analysis]
48 Chinellato A, Ragazzi E, Pandolfo L, Froldi G, Bevilacqua C, Prosdocimi M, Caparrotta L, Fassina G. Protective role of heparin on in vitro functional aortic response in Watanabe heritable hyperlipidemic rabbits. Atherosclerosis 1992;92:17-24. [DOI: 10.1016/0021-9150(92)90005-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
49 Silverman DJ, Santucci LA, Sekeyova Z. Heparin protects human endothelial cells infected by Rickettsia rickettsii. Infect Immun 1991;59:4505-10. [PMID: 1937810 DOI: 10.1128/iai.59.12.4505-4510.1991] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]